Provided by Tiger Trade Technology Pte. Ltd.

HORIZON KINETICS MEDICAL ETF

35.49
+0.49571.42%
Volume:361
Turnover:12.79K
Market Cap:16.68M
PE:- -
High:35.49
Open:35.33
Low:35.33
Close:34.99
52wk High:37.90
52wk Low:28.87
Shares:469.95K
Float Shares:469.95K
Volume Ratio:0.56
T/O Rate:0.08%
Dividend:0.41
Dividend Rate:1.15%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Goldman Sachs Adjusts Eli Lilly Price Target to $1,371 From $1,367, Maintains Buy Rating

MT Newswires Live
·
Yesterday

AbbVie’s Allergan Aesthetics presents clinical data on skin quality improvement

TIPRANKS
·
Yesterday

Hemab Therapeutics doses first patient in HMB-003 trial

TIPRANKS
·
Yesterday

Sichuan Biokin's Subsidiary to Invest $5 Million in Oncology Drug Developer Connexus Therapeutics

Stock News
·
Yesterday

Fennec presents results from STS-J01 clinical trial evaluating Pedmark

TIPRANKS
·
Yesterday

Fed Rate Decision Finalized, A-Share Market Sees Light Volume Retreat, Grain and Innovative Drug Sectors Gain Momentum | 3A Daily Briefing (September 17, 2026)

Deep News
·
Yesterday

ETF Market Wrap (09.17) - Fed Hawkish Stance Weighs on Sentiment; AI Drug Development Bolsters Pharma Gains

Stock News
·
Yesterday

Big Pharma's AI Push Triggers Rally Across A-Shares and CRO Sector

Deep News
·
Yesterday

Guizhou Bailing Unit Gets China Regulator's Nod to Trial Tangning Tongluo Cream

MT Newswires Live
·
Yesterday

GenScript Biotech Hits Near 5-Year High on Eli Lilly Collaboration

Reuters
·
Yesterday

Mid-Year Drug Sector Report Shows Growing Momentum, Analysts Back Innovative Therapies and Supply Chain Players

Stock News
·
Yesterday

Mountain County Embraces a New Wave of Technological Innovation

Deep News
·
Yesterday

Longeveron’s laromestrocel did not meet primary endpoint in Phase 2b HLHS trial

TIPRANKS
·
Yesterday

These ETFs Could Thrive in a Market Overcome by Interest-Rate Worries

Dow Jones
·
Yesterday

Novartis Halts ALS Drug Development After Phase 2 Trial Miss

MT Newswires Live
·
Yesterday

Novartis AG Rises Wednesday

Dow Jones
·
Yesterday

Novartis to End ALS Trial Amid String of Study Failures

Dow Jones
·
Sep 16

Optimi Health to Launch Phase 3 MDMA Trial for PTSD in Veterans and Frontline Workers

TIPRANKS
·
Sep 16

Pharma Sector Doubles Down on AI to Slash Costs, Timelines

Reuters
·
Sep 16

Sector Update: Healthcare

MT Newswires Live
·
Sep 16